You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 1, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
Published on: December 16, 2022
Junko Kurokawa1, Satoshi Shimizu1, Kazuho Sakamoto1
1Department of Bio-informational Pharmacology, Faculty of Pharmaceutical Sciences, University of Shizuoka.
Predicting anti-cancer drug cardiotoxicity using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) shows promise. Optimizing experimental systems for evaluating hiPSC-CM contractile function is crucial for patient-specific toxicity prediction.
Area of Science:
05:06Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022